Published in J Cell Biochem on December 15, 2005
Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages. Free Radic Biol Med (2007) 1.00
The anti-apoptotic effect of regucalcin is mediated through multisignaling pathways. Apoptosis (2013) 0.93
Aberrant epigenetic changes and gene expression in cloned cattle dying around birth. BMC Dev Biol (2008) 0.85
Imprinted genes and satellite loci are differentially methylated in bovine somatic cell nuclear transfer clones. Cell Reprogram (2013) 0.80
A hypothetical model of crossing Bombyx mori nucleopolyhedrovirus through its host midgut physical barrier. PLoS One (2014) 0.79
Senescence Marker Protein 30: Functional and Structural Insights to its Unknown Physiological Function. Biomol Concepts (2012) 0.77
Induction of renal senescence marker protein-30 (SMP30) expression by testosterone and its contribution to urinary calcium absorption in male rats. Sci Rep (2016) 0.75
Regucalcin expression in bovine tissues and its regulation by sex steroid hormones in accessory sex glands. PLoS One (2014) 0.75
Growth inhibition of cultured human liver carcinoma cells by Ki-energy (life-energy): scientific evidence for Ki-effects on cancer cells. Evid Based Complement Alternat Med (2005) 2.60
Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A (2010) 1.38
Royal jelly prevents osteoporosis in rats: beneficial effects in ovariectomy model and in bone tissue culture model. Evid Based Complement Alternat Med (2006) 0.97
Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo. Nanomedicine (2011) 0.95
Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem (2003) 0.89
Overexpression of regucalcin suppresses cell death in cloned rat hepatoma H4-II-E cells induced by tumor necrosis factor-alpha or thapsigargin. J Cell Biochem (2004) 0.88
Oral administration of beta-cryptoxanthin induces anabolic effects on bone components in the femoral tissues of rats in vivo. Biol Pharm Bull (2004) 0.85
Ki-energy (life-energy) stimulates osteoblastic cells and inhibits the formation of osteoclast-like cells in bone cell culture models. Evid Based Complement Alternat Med (2007) 0.84
Oral administration of beta-cryptoxanthin prevents bone loss in ovariectomized rats. Int J Mol Med (2006) 0.83
beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J Cell Biochem (2005) 0.83
Role of regucalcin in liver nuclear function: binding of regucalcin to nuclear protein or DNA and modulation of tumor-related gene expression. Int J Mol Med (2004) 0.82
Albumin regulates Runx2 and alpha1 (I) collagen mRNA expression in osteoblastic cells: comparison with insulin-like growth factor-I. Int J Mol Med (2005) 0.82
Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells. J Cell Biochem (2007) 0.82
Role of endogenous regucalcin in nuclear regulation of regenerating rat liver: suppression of the enhanced ribonucleic acid synthesis activity. J Cell Biochem (2002) 0.82
Alteration in serum and bone component findings induced in streptozotocin-diabetic rats is restored by zinc acexamate. Int J Mol Med (2003) 0.81
Overexpression of regucalcin enhances its nuclear localization and suppresses L-type Ca2+ channel and calcium-sensing receptor mRNA expressions in cloned normal rat kidney proximal tubular epithelial NRK52E cells. J Cell Biochem (2006) 0.81
Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol (2004) 0.81
Suppressive role of endogenous regucalcin in the enhancement of deoxyribonucleic acid synthesis activity in the nucleus of regenerating rat liver. J Cell Biochem (2002) 0.81
Nuclear localization of regucalcin is enhanced in culture with protein kinase C activation in cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med (2008) 0.80
A novel regucalcin gene promoter region-related protein: comparison of nucleotide and amino acid sequences in vertebrate species. Int J Mol Med (2005) 0.80
Nuclear localization of a novel protein, RGPR-p117, in cloned normal rat kidney proximal tubular epithelial cells. Int J Mol Med (2005) 0.80
Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by lipopolysaccharide, PD 98059, dibucaine, or Bay K 8644. J Cell Biochem (2004) 0.80
Phytocomponent p-hydroxycinnamic acid inhibits osteoclast-like cell formation in mouse bone marrow cultures. Int J Mol Med (2007) 0.80
Hormonal regulation on regucalcin mRNA expression in cloned normal rat kidney proximal tubular epithelial NRK52E cells. J Cell Biochem (2005) 0.80
Role of albumin in osteoblastic cells: enhancement of cell proliferation and suppression of alkaline phosphatase activity. Int J Mol Med (2004) 0.80
Identification of transcription factor in the promoter region of rat regucalcin gene: binding of nuclear factor I-A1 to TTGGC motif. J Cell Biochem (2002) 0.79
Phytocomponent p-hydroxycinnamic acid stimulates bone formation and inhibits bone resorption in rat femoral tissues in vitro. Mol Cell Biochem (2006) 0.79
Overexpression of RGPR-p117 enhances regucalcin gene expression in cloned normal rat kidney proximal tubular epithelial cells. Int J Mol Med (2005) 0.79
Regucalcin increases Ca2+-ATPase activity in the heart mitochondria of normal and regucalcin transgenic rats. Int J Mol Med (2006) 0.79
Anabolic effect of beta-cryptoxanthin in osteoblastic MC3T3-E1 cells is enhanced with 17beta-estradiol, genistein, or zinc sulfate in vitro: the unique effect with zinc on Runx2 and alpha1(I) collagen mRNA expressions. Mol Cell Biochem (2007) 0.79
Expression of albumin in bone tissues and osteoblastic cells: involvement of hormonal regulation. Int J Mol Med (2004) 0.78
Synergistic effect of beta-cryptoxanthin and zinc sulfate on the bone component in rat femoral tissues in vitro: the unique anabolic effect with zinc. Biol Pharm Bull (2005) 0.78
Oral administration of beta-cryptoxanthin prevents bone loss in streptozotocin-diabetic rats in vivo. Biol Pharm Bull (2005) 0.78
Overexpression of regucalcin suppresses cell proliferation of cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med (2005) 0.78
Beta-cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: change in their related gene expression. J Cell Biochem (2006) 0.77
Suppression of regucalcin mRNA expression in the hearts of rats administered with free radical compound: the administration-induced death is accelerated in regucalcin transgenic rats. Int J Mol Med (2007) 0.77
Regucalcin increases superoxide dismutase activity in rat liver cytosol. Biol Pharm Bull (2004) 0.77
beta-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells. Int J Mol Med (2005) 0.77
Regucalcin increases superoxide dismutase activity in the heart cytosol of normal and regucalcin transgenic rats. Int J Mol Med (2004) 0.77
Overexpression of regucalcin suppresses apoptotic cell death in the cloned rat hepatoma H4-II-E cells induced by a naturally occurring isothiocyanate sulforaphane. Int J Mol Med (2005) 0.77
Overexpression of regucalcin enhances glucose utilization and lipid production in cloned rat hepatoma H4-II-E cells: Involvement of insulin resistance. J Cell Biochem (2006) 0.77
Suppressive role of endogenous regucalcin in the regulation of nitric oxide synthase activity in heart muscle cytosol of normal and regucalcin transgenic rats. Int J Mol Med (2002) 0.77
Regulatory effect of regucalcin on nitric oxide synthase activity in rat kidney cortex cytosol: Role of endogenous regucalcin in transgenic rats. Int J Mol Med (2003) 0.77
Suppressive effect of regucalcin on protein phosphatase activity in the heart cytosol of normal and regucalcin transgenic rats. Int J Mol Med (2004) 0.76
Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells. J Cell Biochem (2007) 0.76
Overexpression of RGPR-p117 enhances regucalcin gene promoter activity in cloned normal rat kidney proximal tubular epithelial cells: involvement of TTGGC motif. J Cell Biochem (2006) 0.76
Overexpression of RGPR-p117 induces the decrease in protein and DNA contents in cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med (2007) 0.76
Characterization of protein tyrosine phosphatase activity in rat liver microsomes: suppressive effect of endogenous regucalcin in transgenic rats. Int J Mol Med (2004) 0.76
Overexpression of regucalcin suppresses gene expression of insulin signaling-related proteins in cloned rat hepatoma H4-II-E cells: involvement of insulin resistance. Int J Mol Med (2007) 0.76
Bone loss in regucalcin transgenic rats: enhancement of osteoclastic cell formation from bone marrow of rats with increasing age. Int J Mol Med (2004) 0.76
Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by insulin or insulin-like growth factor-I. J Cell Biochem (2005) 0.76
Suppressive effect of endogenous regucalcin on nitric oxide synthase activity in cloned rat hepatoma H4-II-E cells overexpressing regucalcin. J Cell Biochem (2003) 0.76
Gene expression for a novel protein RGPR-p117 in various species: the stimulation by intracellular signaling factors. J Cell Biochem (2002) 0.76
Inhibitory role of regucalcin in the regulation of nitric oxide synthase activity in rat brain cytosol: involvement of aging. J Neurol Sci (2003) 0.76
Role of endogenous regucalcin in transgenic rats: suppression of protein tyrosine phosphatase and ribonucleic acid synthesis activities in liver nucleus. Int J Mol Med (2003) 0.75
Suppressive effect of endogenous regucalcin on deoxyribonuclic acid synthesis in the nuclei of rat renal cortex. Mol Cell Biochem (2002) 0.75
Genistein and zinc synergistically enhance gene expression and mineralization in osteoblastic MC3T3-E1 cells. Int J Mol Med (2007) 0.75
Involvement of nuclear factor I-A1 in the regulation of regucalcin gene promoter activity in cloned normal rat kidney proximal tubular epithelial cells. Int J Mol Med (2006) 0.75
Endogenous regucalcin suppresses the enhancement of protein phosphatase activity in the cytosol and nucleus of kidney cortex in calcium-administered rats. J Cell Biochem (2002) 0.75
Great increase in bone 66 kDa protein and osteocalcin at later stages with healing rat fractures: effect of zinc treatment. Int J Mol Med (2003) 0.75
Decrease in regucalcin level and enhancement of protein tyrosine phosphatase activity in rat brain microsomes with increasing age. Int J Mol Med (2003) 0.75
Regulatory effect of exogenous regucalcin on cell function in osteoblastic MC3T3-E1 cells: involvement of intracellular signaling factor. Int J Mol Med (2006) 0.75
Role of endogenous regucalcin in brain function: suppression of cytosolic nitric oxide synthase and nuclear protein tyrosine phosphatase activities in brain tissue of transgenic rats. Int J Mol Med (2003) 0.75
Effects of copper on bone component in the femoral tissues of rats: anabolic effect of zinc is weakened by copper. Biol Pharm Bull (2005) 0.75
Suppressive effect of endogenous regucalcin on protein tyrosine phosphatase activity in the nucleus of rat brain: attenuation with increasing age. Int J Mol Med (2003) 0.75